ANGELINE WALKER: Open Payments
NPI 1760050413 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,201 in 58 payments from 15 companies in 2025. Trend: 2023 $1,944 · 2024 $1,939 · 2025 $1,201
Food & beverage: $1,201
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $253 |
| Alkermes, Inc. | 6 | $153 |
| Otsuka America Pharmaceutical, Inc. | 6 | $117 |
| ABBVIE INC. | 5 | $101 |
| Janssen Pharmaceuticals, Inc | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $93 |
| Teva Pharmaceuticals USA, Inc. | 3 | $86 |
| Lundbeck LLC | 4 | $74 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Sage Therapeutics, LLC | 1 | $38 |
Products named: INGREZZA, ARISTADA, INVEGA SUSTENNA, REXULTI, VRAYLAR, CAPLYTA, UZEDY, Auvelity.
Industry payments across CO — which companies pay providers there.
